$9.72
-0.27-2.70%
At close: -
$9.72
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Nurix Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NRIX | Benzinga
Nurix Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 8
EPS
$-0.670
Quarterly Revenue
$18.45M
Annual Revenue
(as of Feb 28)
(as of Feb 28)
$56.42M
Analyze the earnings history of Nurix Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics | -$0.71 | — | — | — | $12.09M | — | — | — | 07/10/2025 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.76 | -$0.78 | -$0.67 | 14.10% | $16.59M | $12.71M | $18.45M | 45.18% | 04/08/2025 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.77 | -$0.71 | -$0.75 | -5.63% | $15.16M | $12.86M | $13.28M | 3.31% | 01/28/2025 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.68 | -$0.72 | -$0.67 | 6.94% | $18.47M | $15.76M | $12.59M | -20.13% | 10/11/2024 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.45 | -$0.64 | -$0.71 | -10.94% | $30.68M | $22.89M | $12.09M | -47.17% | 07/11/2024 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.75 | -$0.80 | -$0.76 | 5.00% | $12.69M | $16.64M | $16.59M | -0.33% | 04/10/2024 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.87 | -$0.57 | -$0.77 | -35.09% | $6.78M | $22.26M | $15.16M | -31.90% | 02/15/2024 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.90 | -$0.76 | -$0.68 | 10.53% | $10.79M | $17.23M | $18.47M | 7.18% | 10/12/2023 | Get Alert |
| NRIX | Nurix Therapeutics | -$1.01 | -$0.56 | -$0.45 | 19.64% | $11.43M | $26.21M | $30.68M | 17.04% | 07/13/2023 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.95 | -$0.87 | -$0.75 | 13.79% | $9.62M | $10.87M | $12.69M | 16.70% | 04/13/2023 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.85 | -$0.79 | -$0.87 | -10.13% | $7.40M | $17.17M | $6.78M | -60.50% | 02/09/2023 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.65 | -$0.98 | -$0.90 | 8.16% | $10.25M | $12.08M | $10.79M | -10.67% | 10/06/2022 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.60 | -$0.99 | -$1.01 | -2.02% | $7.09M | $10.50M | $11.43M | 8.88% | 07/07/2022 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.63 | -$0.88 | -$0.95 | -7.95% | $5.01M | $9.27M | $9.62M | 3.79% | 04/07/2022 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.51 | -$0.69 | -$0.85 | -23.19% | $6.69M | $13.19M | $7.40M | -43.93% | 01/27/2022 | Get Alert |
| NRIX | Nurix Therapeutics | -$1.09 | -$0.62 | -$0.65 | -4.84% | $4.08M | $8.57M | $10.25M | 19.63% | 10/14/2021 | Get Alert |
| NRIX | Nurix Therapeutics | — | -$0.54 | -$0.60 | -11.11% | $4.18M | $8.23M | $7.09M | -13.84% | 07/13/2021 | Get Alert |
| NRIX | Nurix Therapeutics | — | -$0.46 | -$0.63 | -36.96% | — | $7.94M | $5.01M | -36.89% | 04/13/2021 | Get Alert |
| NRIX | Nurix Therapeutics | -$3.55 | -$0.54 | -$0.51 | 5.56% | — | $3.94M | $6.69M | 69.77% | 02/16/2021 | Get Alert |
| NRIX | Nurix Therapeutics | -$0.66 | -$0.41 | -$0.59 | -43.90% | $10.58M | $6.34M | $4.08M | -35.57% | 10/14/2020 | Get Alert |
Nurix Therapeutics (NRIX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-04-08 | $-0.67 | $-0.78 | 14.1 % |
| Q4 | 2025-01-28 | $-0.75 | $-0.71 | -5.63 % |
| Q3 | 2024-10-11 | $-0.67 | $-0.72 | 6.94 % |
| Q2 | 2024-07-11 | $-0.71 | $-0.64 | -10.9 % |
Nurix Therapeutics (NRIX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-04-08 | $18.45M | $12.71M | 45.2 % |
| Q4 | 2025-01-28 | $13.28M | $12.86M | 3.31 % |
| Q3 | 2024-10-11 | $12.59M | $15.76M | -20.1 % |
| Q2 | 2024-07-11 | $12.09M | $22.89M | -47.2 % |
FAQ
When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?
Nurix Therapeutics (NRIX) is scheduled to report earnings on July 10, 2025. The last reported earnings were for reported on April 8, 2025 for Q1.
What were the latest earnings per share (EPS) for Nurix Therapeutics (NASDAQ:NRIX)?
The Actual EPS was $-0.67, which beat the estimate of $-0.78.
What were Nurix Therapeutics’s (NASDAQ:NRIX) revenues?
The Actual Revenue was $18.5M, which beat the estimate of $12.7M.
Browse earnings estimates, EPS, and revenue on all stocks.
